Brian Cottier
Clatterbridge Cancer Centre NHS Foundation Trust · 24 works · 1,770 citations · h-index 12
Top works
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
- Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project
- Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome
- Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: Work package 1
- Surgical management and outcomes of colorectal cancer liver metastases
- Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene?
- The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer.
- A National Audit of Radiotherapy in Head and Neck Cancer
- Confirmatory activity of gemcitabine in non small cell lung cancer (NSCLC)
- 24 Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC)
- Overview of brachytherapy resources in Europe: A survey of patterns of care study for brachytherapy in Europe
- A DELAY IN RADICAL CYSTECTOMY OF >3 MONTHS IS NOT ASSOCIATED WITH A WORSE CLINICAL OUTCOME
- [A phase II multicenter study of gemcitabine in non small cell lung cancers].
- The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy
- The Management of Interruptions to Radiotherapy in Head and Neck Cancer: An Audit of the Effectiveness of National Guidelines
- Patterns of care for brachytherapy in Europe results in Spain
- The need for a revised staging system of metastatic (M) colorectal cancer (CRC): Evidence from a national perspective on survival following surgically treated (HPX) liver metastases
- 1052 RECENT TRENDS IN INCIDENCE AND MORTALITY OF PENILE CANCER IN ENGLAND
- Etude multicentrique de phase II de la gemcitabine dans les cancers bronchiques non à petites cellules (CBNPC)
- Platelet density and volume heterogeneity in myeloproliferative disease.